We value your privacy

This website or its third-party tools process personal data. You can opt out of the sale of your personal information by clicking on the “Do Not Sell or Share My Personal Information” link.

Powered by

EPIDIOLEX

ACNU Feasibility

View full report
GoodEpidiolex, an oral solution requiring weight-based dosing and liver monitoring, has moderate side effects and interaction risks, low misuse potential, and moderate adherence challenges, reflecting significant safety and usability considerations per FDA ACNU guidelines.

ACNU Feasibility Scorecard

Chart with 11 data points.
EPIDIOLEX
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying ← Lower is Better!. Data ranges from 1 to 6.
End of interactive chart.